BGEVX
Price
$14.59
Change
-$0.05 (-0.34%)
Updated
Sep 18 closing price
Net Assets
2.91B
CEUAX
Price
$62.60
Change
-$0.14 (-0.22%)
Updated
Sep 18 closing price
Net Assets
140.03B
Interact to see
Advertisement

BGEVX vs CEUAX

BGEVX vs CEUAX Comparison Chart in %
View a ticker or compare two or three
VS
BGEVX vs. CEUAX commentary
Sep 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGEVX is a Hold and CEUAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CEUAX has more cash in the bank: 140B vs. BGEVX (2.91B). CEUAX pays higher dividends than BGEVX: CEUAX (2.52) vs BGEVX (0.21). BGEVX was incepted earlier than CEUAX: BGEVX (14 years) vs CEUAX (25 years). CEUAX (0.86) is less costly to investors than BGEVX (0.42). CEUAX is a more actively managed with annual turnover of: 50.00 vs. BGEVX (21.00). CEUAX has a lower initial minimum investment than BGEVX: CEUAX (250) vs BGEVX (500000000). CEUAX annual gain was more profitable for investors over the last year : 2.04 vs. BGEVX (-5.66). CEUAX return over 5 years is better than : -4.19 vs. BGEVX (-31.58).
BGEVXCEUAXBGEVX / CEUAX
Total Expense Ratio0.420.8649%
Annual Report Gross Expense Ratio0.420.8649%
Fund Existence14 years25 years-
Gain YTD3.9675.42373%
Front LoadN/A4%-
Min. Initial Investment500000000250200,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.91B140B2%
Annual Yield % from dividends0.212.528%
Returns for 1 year-5.662.04-278%
Returns for 3 years27.3627.28100%
Returns for 5 years-31.58-4.19753%
Returns for 10 years39.8551.8477%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FACGX185.571.03
+0.56%
Fidelity Advisor Growth Opps C
HIBCX52.180.13
+0.25%
Hartford Capital Appreciation HLS IB
RYVFX11.69-0.06
-0.51%
Royce Small-Cap Value Service
HFCSX34.31-0.19
-0.55%
Hennessy Focus Investor
FBTDX170.40-3.12
-1.80%
Franklin Biotechnology Discovery C